Patent ID: 11884736
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The antibody or antigen-binding fragment thereof of claim 1, wherein:
(a) HCDR1 comprises an amino acid sequence of SEQ ID NO: 4, 24, or 42;
(b) HCDR2 comprises an amino acid sequence of SEQ ID NO: 6, 26, or 44;
(c) HCDR3 comprises an amino acid sequence of SEQ ID NO: 8, 28, or 46;
(d) LCDR1 comprises an amino acid sequence of SEQ ID NO: 12, 32, or 50;
(e) LCDR2 comprises an amino acid sequence of SEQ ID NO: 14 or 52; and
(f) LCDR3 comprises an amino acid sequence of SEQ ID NO: 16, 34, or 54.